Sami Alobaidi MD

Professor of Medicine and Consultant, Transplant Nephrologist

18 Years of Experience

Languages:

Education

1997 - 2003 Medical School

Bachelor’s Degree in Medicine and Surgery

King Abdulaziz University, Jeddah, KSA

2004 - 2006 Residency

Resident, Internal Medicine

King Faisal Specialist Hospital and Research Center, Riyadh, KSA

2007 - 2010 Residency

Resident, Internal Medicine

St. Elizabeth Medical Center/ Tufts University School of Medicine, USA

2010 - 2012 Fellowship

Maine Medical Center, Tufts University School of Medicine, USA

Nephrology fellowship

2012 - 2013 Fellowship

Oregon Health and Science University, USA

Transplant Nephrology Fellowship

2021 - Present

Consultant, Transplant Nephrology

International Medical Centre in Jeddah, Saudi Arabia

2015 - Present

Assistant Professor of Medicine

Faculty of Medicine at University of Jeddah

2020 - Present

Director of Internal Medicine Residency Joint Program in the second sector ( Western Region)

Saudi Commission for Health Specialties

2013 - 2020

Consultant Transplant Nephrologist

Dr. Soliman Fakeeh Hospital in Jeddah, KSA

2013

American Society of Transplantation

Transplant Nephrology Certification

Off-Pump Coronary Artery Bypass Surgery and Acute Kidney Injury: A Meta-Analysis of Randomized Controlled Trials Clinical Journal of the American Society of Nephrology 10/2010 5): (10) 1734-1744, Victor F. Seabra, Sami Alobaidi, Ethan M. Balk, Bertrand Jaber
Chest pain after kidney transplantation due to pneumomediastinum: a Case Report, Transplantation Proceedings 2013 Sep;45(7):2811-4,Eric S Kerns, MD; Sami A Alobaidi, MD; Kayvan Roayaie, MD, PhD; Jagdeep S Obhrai, MD
Skills in Rheumatology: Renal system and Rheumatology chapter Sami Alobaidi, Manal Alotaibi, Noura Alzahrani Elsevier 2016
Living-Donor Kidney Transplant-Associated Thrombotic Microangiopathy Successfully Treated With Thymoglobulin: A Case Report. Akl A, Alobaidi S, Aboalsamh G., Exp Clin Transplant. 2019 Jan;17(Suppl 1):175-177. doi:10.6002/ect.MESOT2018.P51
Three months interval therapy of Eculizumab in a patient with atypical hemolytic uremic syndrome with hybrid CFHR1/CFH gene. Alobaidi S, AlDabbagh A, Alamoudi A, Almowarey M, Akl A. CEN Case Rep. 2019 Feb 4. doi: 10.1007/s13730-019-00383-7
MEMBRANO-PROLIFERATIVE GLOMERULONEPHRITIS POST DENGUE VIRUS FEVER: A CASE REPORT S Alobaidi, H BALI, A Akl Kidney International Reports 5 (3), S178